首页 | 本学科首页   官方微博 | 高级检索  
     


High-density lipoprotein phospholipids interfere with dendritic cell Th1 functional maturation
Authors:Perrin-Cocon Laure  Diaz Olivier  Carreras Martine  Dollet Sandra  Guironnet-Paquet Aurélie  André Patrice  Lotteau Vincent
Affiliation:a Université de Lyon, France
b INSERM, U851, 21 Avenue Tony Garnier, Lyon F-69365, France
c Hospices Civils de Lyon, Hôpital de la Croix Rousse, Laboratoire de Virologie, France
Abstract:Lipoproteins are both lipid carriers in the blood and regulators of essential biological processes. Several studies demonstrated that lipoproteins modified during pathological conditions could alter dendritic cell (DC) maturation. Here the immune function of non-pathological lipoproteins is addressed by analysing their impact on human DC maturation triggered by TLR ligands. Upon TLR4 stimulation, low- and high-density lipoproteins (LDL and HDL) strongly inhibited the ability of DC to induce a Th1 response of T cells, characterized by high levels of IFNγ secretion, whereas the effect of very low-density lipoprotein was subject to variations. HDL also inhibited the Th1 function of DC stimulated by TLR1/2 and TLR2/6 ligands. The phospholipid fraction from HDL retained the inhibitory activity of the lipoprotein. We identified the 1-palmitoyl-2-linoleyl-phosphatidylcholine (PLPC) as one active phospholipid that inhibited the Th1 function of mature DCs whereas the dipalmitoyl-phosphatidylcholine had no significant effect. The treatment of DC by PLPC, 24 h before TLR4 stimulation, resulted in reduced activation of NF-κB. This study shows that some HDL phospholipids have a direct immunoregulatory function, by modulating DC ability to activate a Th1 response of T cells.
Keywords:VLDL, very low density lipoprotein   IDL, intermediate density lipoprotein   LDL, low density lipoprotein   HDL, high density lipoprotein   oxLDL, oxidized LDL   Apo, apolipoprotein   DC, dendritic cells   IL, interleukin   IFN, interferon   TLR, Toll-like receptor   LPS, lipopolysaccharide   PGN, peptidoglycan   pIC, poly(I)/poly(C)   Pam, Pam3CSK4   MLR, mixed leukocyte reaction   LPDS, lipoprotein-deficient foetal calf serum   PL, phospholipid   TG, triglyceride   CE, cholesteryl ester   PC, phosphatidylcholine   PLPC, 1-palmitoyl-2-linoleyl-phosphatidylcholine   POPC, 1-palmitoyl-2-oleoyl-phosphatidyl-choline   SLPC, 1-stearoyl-2-linoleyl-phosphatidylcholine   PAPC, 1-palmitoyl-2-arachidonoyl-phosphatidylcholine   PPPC, dipalmitoyl-phosphatidylcholine   LPC, lysophosphatidylcholine   LA, linoleic acid   HODE, hydroxy-octadecadienoic acid   PPAR, peroxisome proliferator-activated receptor   EMSA, electrophoretic mobility shift assay
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号